Jyothy Laboratories Net Income jumped on 48.7% in 2015 and EBITDA Margin increased slightly on 0.89 pp from 11.9% to 12.8%
25-05-2015 • About Jyothy Laboratories (
$JYOTHYLAB) • By InTwits
Jyothy Laboratories reported FY2015 financial results today. Overall the company's long term financial model is characterised by the following facts:
- Jyothy Laboratories has low CAPEX intensity: 5 year average CAPEX/Revenue was 2.6%. At the same time it's in pair with industry average of 11.5%.
- CAPEX is quite volatile: 211 in FY2015, 1,941 in FY2014, 4,346 in FY2013, 4,084 in FY2012, 4,033 in FY2011
- The company has highly profitable business model: ROIC is at 12.1%
- It operates with medium-size leverage: Net Debt/EBITDA is 2.8x while industry average is 2.7x
Below you can find a comprehensive analysis of the key data driving the company's performance and stock price.
Jyothy Laboratories ($JYOTHYLAB) key annual financial indicators
| mln. INR | 2011 | 2012 | 2013 | 2014 | 2015 | 2015/2014 |
|---|
P&L
|
|---|
| Revenue | 6,195 | 9,126 | 11,042 | 13,184 | 15,053 | 14.2% |
| EBITDA | 847 | 869 | 1,309 | 1,573 | 1,931 | 22.7% |
| Net Income | 688 | 446 | 196 | 814 | 1,211 | 48.7% |
Balance Sheet
|
|---|
| Cash | 2,795 | 662 | 192 | 354 | 309 | -12.5% |
| Short Term Debt | 583 | 1,237 | 2,027 | 68 | 1,204 | 1,676.1% |
| Long Term Debt | 77 | 4,379 | 4,268 | 5,268 | 4,490 | -14.8% |
Cash flow
|
|---|
| Capex | 288 | 247 | 279 | 237 | 171 | -28.0% |
Ratios
|
|---|
| Revenue growth | -65.8% | 47.3% | 21.0% | 19.4% | 14.2% | |
| EBITDA growth | -12.7% | 2.6% | 50.7% | 20.2% | 22.7% | |
| EBITDA Margin | 13.7% | 9.5% | 11.9% | 11.9% | 12.8% | 0.9% |
| Net Income Margin | 11.1% | 4.9% | 1.8% | 6.2% | 8.0% | 1.9% |
| CAPEX, % of revenue | 4.6% | 2.7% | 2.5% | 1.8% | 1.1% | -0.7% |
| ROIC | 12.6% | 6.5% | 8.7% | 10.3% | 12.1% | 1.7% |
| ROE | 13.5% | 7.2% | 3.1% | 11.9% | 16.0% | 4.1% |
| Net Debt/EBITDA | -2.5x | 5.7x | 4.7x | 3.2x | 2.8x | -0.4x |
Revenue and profitability
Jyothy Laboratories's Revenue surged on 14.2% in FY2015. Having declining revenue the company managed to increase EBITDA margin. EBITDA Margin increased on 2.6 pp from 2.4% to 5.0% in FY2015.
Net Income marign increased slightly on 1.9 pp from 6.2% to 8.0% in FY2015.
Capital expenditures (CAPEX) and working capital investments
The company's CAPEX/Revenue was 1.1% in FY2015. CAPEX/Revenue decreased slightly on 1.6 pp from 2.7% in FY2012 to 1.1% in FY2015. For the last three years the average CAPEX/Revenue was 1.8%.
Return on investment
The company operates at good ROIC (12.09%) and ROE (16.00%). ROIC increased slightly on 1.7 pp from 10.3% to 12.1% in FY2015. ROE increased on 4.1 pp from 11.9% to 16.0% in FY2015.
Leverage (Debt)
Debt level is 2.8x Net Debt / EBITDA and 2.9x Debt / EBITDA. Net Debt / EBITDA dropped on 0.4x from 3.2x to 2.8x in FY2015. Debt increased on 6.7% in FY2015 while cash dropped on 12.5% in FY2015.
Valuation
Jyothy Laboratories's trades at EV/EBITDA 27.5x and P/E 39.3x while industy averages are 10.5x and 26.1x. The company's EV/(EBITDA-CAPEX) is 30.1x with the industry average at 4.7x.
Appendix 1: Peers in Household Products
Below you can find Jyothy Laboratories benchmarking vs. other companies in Household Products industry. It's shown for the period of 5 years for the key financial metrics. Each table has median value for all the companies in the industry together with individual financial data of the top-5 companies in the industry by particular financial metric.
Top companies by Revenue growth, %
| Top | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|
| Ess Dee Aluminium ($ESSDEE) | -33.8% | -3.2% | 9.1% | 0.1% | |
| |
|---|
| Median (1 company) | -33.8% | -3.2% | 9.1% | 0.1% | |
|---|
| Jyothy Laboratories ($JYOTHYLAB) | | 47.3% | 21.0% | 19.4% | 14.2% |
Top companies by EBITDA margin, %
| Top | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|
| Ess Dee Aluminium ($ESSDEE) | 26.6% | 23.3% | 21.9% | 24.7% | |
| |
|---|
| Median (1 company) | 26.6% | 23.3% | 21.9% | 24.7% | |
|---|
| Jyothy Laboratories ($JYOTHYLAB) | 13.7% | 9.5% | 11.9% | 11.9% | 12.8% |
Top companies by CAPEX/Revenue, %
| Top | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|
| Ess Dee Aluminium ($ESSDEE) | 23.2% | 19.3% | 16.8% | 35.2% | |
| |
|---|
| Median (1 company) | 23.2% | 19.3% | 16.8% | 35.2% | |
|---|
| Jyothy Laboratories ($JYOTHYLAB) | 4.6% | 2.7% | 2.5% | 1.8% | 1.1% |
Top companies by ROIC, %
| Top | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|
| Ess Dee Aluminium ($ESSDEE) | 21.7% | 11.4% | 9.9% | 10.2% | |
| Hipolin ($HIPOLIN) | -3.3% | 2.2% | 3.3% | | |
| Pee Cee Cosma Sope ($PCCOSMA) | 0.6% | 6.7% | | | |
| |
|---|
| Median (3 companies) | 0.6% | 6.7% | 6.6% | 10.2% | |
|---|
| Jyothy Laboratories ($JYOTHYLAB) | 12.6% | 6.5% | 8.7% | 10.3% | 12.1% |
Top companies by Net Debt / EBITDA
| Top | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|
| Ess Dee Aluminium ($ESSDEE) | 1.1x | 2.2x | 2.4x | 2.6x | |
| |
|---|
| Median (1 company) | 3.1x | 2.2x | 3.6x | 2.6x | |
|---|
| Jyothy Laboratories ($JYOTHYLAB) | -2.5x | 5.7x | 4.7x | 3.2x | 2.8x |